US Stocks
/
Invivyd, Inc. Share Price

Invivyd, Inc. Share Price

NASDAQ: IVVD | Micro Cap
$0.74
+$0.09 (13.34%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Invivyd, Inc. Stock Performance

Open
$0.69
Prev. Close
$0.66
Circuit Range
N/A
Day Range
$0.67 - $0.75
Year Range
$0.49 - $3.05
Volume
31,528
Average Traded
$0.71

Invivyd, Inc. Share Price Today

As of 10 August 2026, Invivyd, Inc.'s share price is $0.74. The stock opened at $0.69, compared to its previous close of $0.66. During today's trading session, Invivyd, Inc.'s share price traded between $0.67 and $0.75, with an average price of $0.71. Over the past 52 weeks, the stock has recorded a high of $3.05 and a low of $0.49. In terms of performance, Invivyd, Inc.'s share price has declined by 56.15% over the last six months and is down 23.45% on a year-on-year basis.

Invivyd, Inc. Share Price Chart

$0.67$0.75
L
Show Current Price
H

Invivyd, Inc. Stock Fundamentals & Key Indicators

Market Cap
$128.01M
PE Ratio (TTM)
-2.48
Dividend Yield
N/A
EPS (TTM)
$-0.30
Revenue (TTM)
$53.43M
Return On Equity (TTM)
-21.73%
Profit Margin
-98.25%
Debt to Equity
0.14
Quarterly Earnings Growth YoY
N/A

About Invivyd, Inc.

Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.

Invivyd, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.55
$0.74
+39.40%
Jul 2026
$0.86
$0.53
-39.36%
Jun 2026
$1.15
$0.88
-23.23%
May 2026
$1.41
$1.15
-17.63%
Apr 2026
$1.32
$1.39
+7.34%
Mar 2026
$1.60
$1.29
-23.60%
Feb 2026
$1.75
$1.70
-2.59%
Jan 2026
$2.48
$1.74
-29.84%
Dec 2025
$2.51
$2.48
+2.06%
Nov 2025
$1.81
$2.43
+37.68%
Oct 2025
$1.12
$1.76
+60.45%
Sep 2025
$0.96
$1.10
+13.29%

IVVD Share Price FAQs

What is Invivyd, Inc. share price today?

chevron-up
Invivyd, Inc. share price today is $0.74 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Invivyd, Inc. stock?

chevron-up
The 52 week high of Invivyd, Inc. stock is $3.05, while the 52 week low is $0.49 as of 8 Aug '26.

What is IVVD's market capitalisation today?

chevron-up
IVVD market capitalisation is $128.01M as of August 10, 2026, at 5:39 am IST.

What is the 5 year returns of IVVD?

chevron-up
The 5 year returns of IVVD is -97.80% as on 8 Aug '26.

What is the high & low stock price of IVVD today?

chevron-up
IVVD stock price hit a high of $0.75 and low of $0.67 as of 8 Aug '26.

Can I buy IVVD shares in India?

chevron-up
Yes. You can buy IVVD in India by opening an international trading account.